300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 15 Biotech Angel Investors in Switzerland (October 2023)

The most active angel investors investing in Switzerland Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Penny Schiffer
Angel
4 Switzerland, Germany, United Kingdom Seed, Series A Health Care, Medical, Finance $533k–$8.9M
Patrick Delarive
Angel
1 Switzerland Seed Security, Wireless, Wearables
John Zimmer
Angel
1 United States, Switzerland Series B, Seed Mining, FinTech, Mineral
Thorsten Schroeder
Angel
1 United States, Brazil, Switzerland Seed, Series B Electronics, Children, Life Science $18M–$23M
Alexsis de Raadt-St. James
Angel
1 United States, Switzerland, United Kingdom Seed, Series A, Series B Software, SaaS, Health Care $250k–$24M
Ulf Claesson
Angel
1 Switzerland Seed Biotechnology, Food and Beverage
Tej Tadi
Angel
1 Switzerland Seed Robotics, Neuroscience
Emily Leproust
Angel
1 Switzerland Seed Biotechnology, Product Research
Lukas Speiser
Angel
1 Germany, Switzerland Seed Wellness, Nutrition, Health Care
Nicolas Mermod
Angel
1 Switzerland Series A Health Care, Biotechnology, Science and Engineering
Arda Kara
Angel
1 United States, Germany, Switzerland Series A, Seed, Series B Health Care, Medical, Software $25M–$27M
Feike Sijbesma
Angel
1 Switzerland Seed Biotechnology, Product Research
Reinhard Ambros
Angel
1 United States, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical
Walter Fischl
Angel
1 Switzerland Medical, Health Care, Biotechnology
Beat Schillig
Angel
1 Switzerland Seed, Series A Information Technology, SaaS, Music $2.2M–$5.1M
Access all 15 angel investors in Switzerland Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Penny Schiffer
Angel · 4 investments in Switzerland Biotech startups

Penny Schiffer - CEO & Co-founder @ Raized.ai

Show more...

Investment focus

  • Industry: Health Care, Medical, Finance
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 33
  • Round size: Seed $533k–$8.9M; Series A $1.1M–$6.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
  • Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Show all investments...

Patrick Delarive
Angel · Lausanne, Vaud, Switzerland · 1 investments in Switzerland Biotech startups

Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.

Show more...

Investment focus

  • Industry: Security, Wireless, Wearables
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Biowatch — Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matchingtheir vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords.Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.
Show all investments...

John Zimmer
Angel · San Francisco Bay Area, California, United States · 1 investments in Switzerland Biotech startups

John Zimmer is the co-founder and President of Lyft, the on-demand ridesharing platform, that was founded in 2007 with Zimride as its first of two products built to create a more social, sustainable and affordable transportation system. John’s interest in peer-to-peer transportation began at Cornell’s School of Hotel Administration. Uponlearning that only 20% of seats in cars on highways are occupied, he began working on ways to use existing information infrastructures to solve the problem of unused empty seats. After graduating first in his class, John spent two years at Lehman Brothers before (luckily) leaving to rideshare his way from New York to San Francisco to join co-founder Logan Green in launching Zimride. John was recognized in 2009 as one of Businessweek's Top 25 Entrepreneurs Under 25, and has spoken at top tier events such as SXSW, The Association for Commuter Transportation (ACT) International Conference and Stanford Business School. With Lyft, John hopes to fix the current state of transportation across the country, and eventually around the world, to make cities safer, more affordable and better connected. Since unveiling the product in June 2012, Lyft has quickly become one of the fastest-growing tech companies with more than $80 million raised from leading investors Andreessen Horowitz and Founders Fund and has been featured in The Economist, the New York Times and on NBC’s TODAY Show. Lyft is currently available in San Francisco, Los Angeles, Seattle, San Diego, Chicago, Boston and Washington, D.C., with more than a million rides shared on the platform to date.

Show more...

Investment focus

  • Industry: Mining, FinTech, Mineral
  • Stage:Series B, Seed
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Deel — With Deel, your business can easily hire anywhere. No more worrying about local laws, complex tax systems, or managing international payroll. Deel takes care of everything in 150+ countries.
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • KoBold Metals — KoBold is a mineral exploration company driving the clean energy future by accelerating the discovery of critical metals.
Show all investments...

Thorsten Schroeder
Angel · 1 investments in Switzerland Biotech startups

Thorsten Schroeder

Show more...

Investment focus

  • Industry: Electronics, Children, Life Science
  • Stage:Seed, Series B
  • Geography: United States, Brazil, Switzerland

Investor stats

  • Total investments: 9
  • Round size: Series B $18M–$23M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
  • TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
  • 4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.
Show all investments...

Alexsis de Raadt-St. James
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotech startups

Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 8
  • Round size: Seed $250k–$2.9M; Series A $2.1M–$24M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
  • Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
  • Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.
Show all investments...

Ulf Claesson
Angel · 1 investments in Switzerland Biotech startups

Ulf Claesson

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment
Show all investments...

Tej Tadi
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotech startups

Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.

Show more...

Investment focus

  • Industry: Robotics, Neuroscience
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.
Show all investments...

Emily Leproust
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotech startups

As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Product Research
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
Show all investments...

Lukas Speiser
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotech startups

Lukas Speiser is the founder and CEO of Amorana.ch

Show more...

Investment focus

  • Industry: Wellness, Nutrition, Health Care
  • Stage:Seed
  • Geography: Germany, Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.
  • Testmate Health — Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home.
Show all investments...

Nicolas Mermod
Angel · 1 investments in Switzerland Biotech startups

Nicolas Mermod

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Science and Engineering
  • Stage:Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Arda Kara
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotech startups

Arda Kara

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 9
  • Round size: Series A $25M–$27M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
  • Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
  • Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Show all investments...

Feike Sijbesma
Angel · 1 investments in Switzerland Biotech startups

Feike has been the CEO and Chairman of the Managing Board of Directors of Royal DSM N.V. (a global Life Sciences and Materials Sciences company) since May 2007. In 1995, Feike became director of Gist-Brocades Food Specialties Division and joined Gist-Brocade’s executive committee. Following the acquisition by Royal DSM N.V. in 1998, he became adirector of the business group DSM Food Specialties. In 2000 he joined Royal DSM’s managing board of directors, becoming Chairman and CEO in May 2007.He is currently a member of the supervisory board of De Nederlandsche Bank (DNB, the Dutch Central Bank), and a board member of CEFIC (European Chemical Industry Council) and member of the Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).His previous roles have included member of the Supervisory Board of DSM Netherlands, the Utrecht University, the Dutch Genomics Initiative (NGI) and the Anthonie van Leeuwenhoek Hospital/Netherlands Cancer Institute (NKI/AVL), chairman of Chemical Governors and a Global Agenda Council of the World Economic Forum, Dutch Food Chain Sustainability Foundation (DUVO) and of EuropaBio (European Biotech Association), a member of the Dutch Innovation Platform 2.0, board member of BIO (US Biotechnology Association), the Swiss Society of Chemical Industries (SCGI) and the Dutch Nutrition/Food Top-Institute (WCFS) and a member of the advisory board of ECP-EPN (e-commerce) and the Rotterdam Business School of the Erasmus University.

Show more...

Investment focus

  • Industry: Biotechnology, Product Research
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
Show all investments...

Reinhard Ambros
Angel · Basel, Basel-Stadt, Switzerland · 1 investments in Switzerland Biotech startups

Reinhard Ambros

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 11
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • FORMA Therapeutics — Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
  • Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Walter Fischl
Angel · 1 investments in Switzerland Biotech startups

Walter Fischl

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • ProteoMediX — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Show all investments...

Beat Schillig
Angel · 1 investments in Switzerland Biotech startups

Beat Schillig - Founder @ Venture Kick

Show more...

Investment focus

  • Industry: Information Technology, SaaS, Music
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $2.2M–$5.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
  • PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
  • 1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in Switzerland Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists